Delta-Fly Pharma (4598) · InitiativeFirst stated

Preparations for Outsourced Manufacturing of Commercial Active Pharmaceutical Ingredients After Launch

First written in FY2019-Q2. . Latest entry: FY2019-Q2.

1entries

1years

0from disclosures

Share on X

How it moved

Same theme, other companies

Reliance on an Outsourced Production SystemA theme 44 companies write about · 44 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2020: 4 of 20 companies on the "Worse" side.

4 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 44 companies compared. The sentences above are computed from all 44.

Full recordFilings, disclosures and news, newest first

FY2019-Q2First statedAnnual report
「We began discussions with a contract manufacturing organization (CRO) regarding the outsourced manufacture of commercial active pharmaceutical ingredients after launch.」
Began discussions to outsource commercial API manufacturing in preparation for the post-launch period.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for Delta-Fly Pharma yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.